Whole blood transcriptional profiles and the pathogenesis of tuberculous meningitis.
human
immunology
infectious disease
inflammation
microbiology
mortality
pathogenesis
prognostic
tuberculous meningitis
whole blood RNA sequencing
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
medline:
30
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
epublish
Résumé
Mortality and morbidity from tuberculous meningitis (TBM) are common, primarily due to inflammatory response to Tuberculous meningitis is a dangerous condition caused by the bacteria responsible for tuberculosis spreading from the lungs to the brain. It affects more than 150,000 adults a year worldwide, and results in death or brain damage in half of all patients. People living with HIV are particularly at risk for negative outcomes. These severe forms of tuberculous meningitis may be linked to the immune system becoming over-active while trying to fight the disease and harming the brain in the process. Detecting this hyperinflammation via blood sample analyzes has remained challenging so far, as traditional approaches can only offer partial information on the inflammatory response. In response, Hai, Nhat et al. took advantage of new genetic approaches to examine the expression of around 20,000 genes in the blood of HIV-positive and HIV-negative patients with tuberculous meningitis or lung tuberculosis, as well as in healthy individuals. Identifying which genes are more or less expressed in the different groups of volunteers can help to better understand the mechanisms associated with tuberculous meningitis, particularly in its most dangerous forms. Such analysis could also allow scientists to pinpoint which genes to monitor to efficiently detect patients at higher risk of severe complications. The results show that tuberculous meningitis mortality was associated with a distinct pattern of immune cell response; white blood cells known as neutrophils were increasingly activated while T and B cells showed decreased activity. Increased mortality was also linked to different patterns of gene activity between patients living with or without HIV. Overall, inflammatory genes were more activated in HIV-positive tuberculous meningitis patients than in their HIV-negative counterparts. Finally, Hai, Nhat et al. found that the blood activity levels of just four specific genes formed a signature associated with increased risk of death from tuberculous meningitis. In the future, medical professionals may be able to use this signature to rapidly identify patients who require intensive care and more specialized treatments. The findings also reveal immune system processes and molecules that may serve as potential drug targets for future therapies against this disease.
Autres résumés
Type: plain-language-summary
(eng)
Tuberculous meningitis is a dangerous condition caused by the bacteria responsible for tuberculosis spreading from the lungs to the brain. It affects more than 150,000 adults a year worldwide, and results in death or brain damage in half of all patients. People living with HIV are particularly at risk for negative outcomes. These severe forms of tuberculous meningitis may be linked to the immune system becoming over-active while trying to fight the disease and harming the brain in the process. Detecting this hyperinflammation via blood sample analyzes has remained challenging so far, as traditional approaches can only offer partial information on the inflammatory response. In response, Hai, Nhat et al. took advantage of new genetic approaches to examine the expression of around 20,000 genes in the blood of HIV-positive and HIV-negative patients with tuberculous meningitis or lung tuberculosis, as well as in healthy individuals. Identifying which genes are more or less expressed in the different groups of volunteers can help to better understand the mechanisms associated with tuberculous meningitis, particularly in its most dangerous forms. Such analysis could also allow scientists to pinpoint which genes to monitor to efficiently detect patients at higher risk of severe complications. The results show that tuberculous meningitis mortality was associated with a distinct pattern of immune cell response; white blood cells known as neutrophils were increasingly activated while T and B cells showed decreased activity. Increased mortality was also linked to different patterns of gene activity between patients living with or without HIV. Overall, inflammatory genes were more activated in HIV-positive tuberculous meningitis patients than in their HIV-negative counterparts. Finally, Hai, Nhat et al. found that the blood activity levels of just four specific genes formed a signature associated with increased risk of death from tuberculous meningitis. In the future, medical professionals may be able to use this signature to rapidly identify patients who require intensive care and more specialized treatments. The findings also reveal immune system processes and molecules that may serve as potential drug targets for future therapies against this disease.
Identifiants
pubmed: 39475467
doi: 10.7554/eLife.92344
pii: 92344
doi:
pii:
Banques de données
Dryad
['10.5061/dryad.s4mw6m9gf']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 10.35802/206724
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 10.35802/106680
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 10.35802/110179
Pays : United Kingdom
Informations de copyright
© 2024, Hai, Thanh Hoang Nhat et al.
Déclaration de conflit d'intérêts
HH, LT, TT, DV, AN, JD, NT, DV, NB, DH, NP, HN, LV, MI, GT, NT No competing interests declared
Références
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
PLoS Comput Biol. 2011 Jan 20;7(1):e1001057
pubmed: 21283776
Wellcome Open Res. 2018 Mar 20;3:32
pubmed: 30363837
Sci Rep. 2019 Jan 29;9(1):884
pubmed: 30696839
J Infect Dis. 2019 Feb 23;219(6):986-995
pubmed: 30299487
Elife. 2023 May 09;12:
pubmed: 37158692
J Immunol. 2002 Oct 1;169(7):3947-53
pubmed: 12244195
Clin Infect Dis. 2018 Feb 1;66(4):523-532
pubmed: 29029055
Clin Respir J. 2022 May;16(5):369-379
pubmed: 35522050
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell. 2016 Oct 6;167(2):433-443.e14
pubmed: 27667685
Cells. 2022 Sep 17;11(18):
pubmed: 36139482
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Genome Biol. 2016 Jan 26;17:13
pubmed: 26813401
BMC Neurol. 2021 Aug 10;21(1):308
pubmed: 34376174
Am J Trop Med Hyg. 2022 Oct 10;107(6):1288-1294
pubmed: 36216321
J Infect Dis. 2017 Mar 1;215(5):677-686
pubmed: 27932622
Lancet Neurol. 2022 May;21(5):450-464
pubmed: 35429482
Clin Infect Dis. 2017 Oct 15;65(8):1298-1307
pubmed: 28605426
Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S421-6
pubmed: 16237641
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Wellcome Open Res. 2018 Mar 20;3:31
pubmed: 30320225
N Engl J Med. 2004 Oct 21;351(17):1741-51
pubmed: 15496623
PLOS Glob Public Health. 2021 Dec 8;1(12):e0000069
pubmed: 36962116
PLoS One. 2017 Nov 15;12(11):e0185973
pubmed: 29140996
J Infect Dis. 2017 Apr 1;215(7):1020-1028
pubmed: 28419368
PLoS One. 2016 Jan 04;11(1):e0146318
pubmed: 26727122
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Wellcome Open Res. 2019 Oct 31;4:164
pubmed: 33364436
Nature. 2010 Aug 19;466(7309):973-7
pubmed: 20725040
Nat Commun. 2018 Jun 19;9(1):2308
pubmed: 29921861
J Infect Public Health. 2022 Jan;15(1):29-35
pubmed: 34883295
N Engl J Med. 2023 Oct 12;389(15):1357-1367
pubmed: 37819954
Bioinformatics. 2020 Apr 15;36(8):2628-2629
pubmed: 31882993
J Clin Epidemiol. 2001 Aug;54(8):774-81
pubmed: 11470385
Sci Rep. 2020 May 25;10(1):8629
pubmed: 32451443
Nature. 2009 Nov 5;462(7269):108-12
pubmed: 19847166
Nat Rev Neurol. 2017 Oct;13(10):581-598
pubmed: 28884751
Nat Commun. 2019 Aug 21;10(1):3767
pubmed: 31434901
Lancet Infect Dis. 2010 Nov;10(11):803-12
pubmed: 20822958
Curr Protoc Bioinformatics. 2017 Sep 13;59:11.15.1-11.15.21
pubmed: 28902396
Clin Infect Dis. 2020 Feb 14;70(5):827-834
pubmed: 30944929
J Infect Dis. 2017 Apr 1;215(7):1029-1039
pubmed: 28419315
Front Immunol. 2022 Aug 18;13:954221
pubmed: 36059536
Open Forum Infect Dis. 2020 Jun 30;7(8):ofaa257
pubmed: 32818138
Braz J Infect Dis. 2008 Dec;12(6):483-6
pubmed: 19287835
Nucleic Acids Res. 2013 Oct;41(18):e170
pubmed: 23921631